HEADER NUCLEAR PROTEIN 25-JUN-14 4TUZ TITLE CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH ALPHA-ZEARALENOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 302-552; COMPND 5 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 6 GROUP A MEMBER 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ESTROGEN RECEPTOR; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: RESIDUES 302-552; COMPND 13 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 14 GROUP A MEMBER 1; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 19 CHAIN: F, G; COMPND 20 FRAGMENT: RESIDUES 686-698; COMPND 21 SYNONYM: NCOA-1,CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 74,BHLHE74, COMPND 22 PROTEIN HIN-2,RIP160,RENAL CARCINOMA ANTIGEN NY-REN-52,STEROID COMPND 23 RECEPTOR COACTIVATOR 1,SRC-1; COMPND 24 EC: 2.3.1.48; COMPND 25 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: ESR1, ESR, NR3A1; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 22 ORGANISM_COMMON: HUMAN; SOURCE 23 ORGANISM_TAXID: 9606 KEYWDS NUCLEAR HORMONE RECEPTOR LIGAND BINDING DOMAIN ENDOCRINE DISRUPTOR KEYWDS 2 ENVIRONMENTAL COMPOUND, NUCLEAR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR V.DELFOSSE,M.GRIMALDI,W.BOURGUET REVDAT 6 23-OCT-24 4TUZ 1 REMARK REVDAT 5 20-DEC-23 4TUZ 1 REMARK REVDAT 4 19-FEB-20 4TUZ 1 REMARK SITE ATOM REVDAT 3 27-FEB-19 4TUZ 1 JRNL REVDAT 2 04-NOV-15 4TUZ 1 JRNL REVDAT 1 28-JAN-15 4TUZ 0 JRNL AUTH V.DELFOSSE,A.L.MAIRE,P.BALAGUER,W.BOURGUET JRNL TITL A STRUCTURAL PERSPECTIVE ON NUCLEAR RECEPTORS AS TARGETS OF JRNL TITL 2 ENVIRONMENTAL COMPOUNDS. JRNL REF ACTA PHARMACOL. SIN. V. 36 88 2015 JRNL REFN ESSN 1745-7254 JRNL PMID 25500867 JRNL DOI 10.1038/APS.2014.133 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.52 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 40069 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2004 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.5415 - 4.5780 0.99 2775 147 0.1862 0.2082 REMARK 3 2 4.5780 - 3.6341 0.98 2718 143 0.1506 0.1867 REMARK 3 3 3.6341 - 3.1749 0.99 2733 144 0.1723 0.1881 REMARK 3 4 3.1749 - 2.8846 0.98 2688 141 0.1709 0.2090 REMARK 3 5 2.8846 - 2.6779 0.99 2702 142 0.1738 0.1921 REMARK 3 6 2.6779 - 2.5200 0.99 2745 145 0.1787 0.2041 REMARK 3 7 2.5200 - 2.3938 0.99 2710 142 0.1823 0.2037 REMARK 3 8 2.3938 - 2.2896 0.99 2717 143 0.1855 0.2364 REMARK 3 9 2.2896 - 2.2015 0.99 2739 145 0.1862 0.2195 REMARK 3 10 2.2015 - 2.1255 0.99 2685 141 0.1904 0.2188 REMARK 3 11 2.1255 - 2.0591 1.00 2726 143 0.1892 0.2357 REMARK 3 12 2.0591 - 2.0002 1.00 2715 143 0.2144 0.2621 REMARK 3 13 2.0002 - 1.9475 1.00 2690 142 0.2325 0.2637 REMARK 3 14 1.9475 - 1.9000 0.99 2722 143 0.2450 0.2868 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.95 REMARK 3 K_SOL : 0.36 REMARK 3 B_SOL : 60.61 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.670 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.82500 REMARK 3 B22 (A**2) : 3.54140 REMARK 3 B33 (A**2) : 1.28360 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.74830 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 4180 REMARK 3 ANGLE : 0.853 5685 REMARK 3 CHIRALITY : 0.058 670 REMARK 3 PLANARITY : 0.003 712 REMARK 3 DIHEDRAL : 17.243 1576 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4TUZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000202310. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-OCT-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.75 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40075 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 46.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.8500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.01 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.39000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.680 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 200 STARTING MODEL: 3UUD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 300-340 MM NACL 100 MM HEPES 24-32 % REMARK 280 PEG 3350, PH 7.75, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.71500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6570 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, F, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 298 REMARK 465 SER A 299 REMARK 465 HIS A 300 REMARK 465 MET A 301 REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU A 469 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 GLY B 298 REMARK 465 SER B 299 REMARK 465 HIS B 300 REMARK 465 MET B 301 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 ASN B 304 REMARK 465 SER B 463 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 ARG F 686 REMARK 465 HIS F 687 REMARK 465 GLY F 697 REMARK 465 SER F 698 REMARK 465 ARG G 686 REMARK 465 HIS G 687 REMARK 465 GLY G 697 REMARK 465 SER G 698 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 306 CG CD1 CD2 REMARK 470 SER A 309 OG REMARK 470 ARG A 335 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 362 NZ REMARK 470 GLU A 397 CD OE1 OE2 REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 GLU A 471 CG CD OE1 OE2 REMARK 470 LYS A 472 CG CD CE NZ REMARK 470 LYS A 492 CD CE NZ REMARK 470 LYS A 531 NZ REMARK 470 ARG A 548 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 306 CG CD1 CD2 REMARK 470 ARG B 335 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 401 NZ REMARK 470 LYS B 416 CD CE NZ REMARK 470 GLU B 419 CG CD OE1 OE2 REMARK 470 GLU B 423 CG CD OE1 OE2 REMARK 470 LEU B 462 CG CD1 CD2 REMARK 470 SER B 464 OG REMARK 470 THR B 465 OG1 CG2 REMARK 470 LEU B 466 CG CD1 CD2 REMARK 470 LYS B 467 CG CD CE NZ REMARK 470 SER B 468 OG REMARK 470 LEU B 469 CG CD1 CD2 REMARK 470 GLU B 470 CG CD OE1 OE2 REMARK 470 GLU B 471 CG CD OE1 OE2 REMARK 470 LYS B 472 CG CD CE NZ REMARK 470 LYS B 492 NZ REMARK 470 LYS B 529 NZ REMARK 470 LYS B 531 CE NZ REMARK 470 VAL B 533 CG1 CG2 REMARK 470 ARG B 548 NE CZ NH1 NH2 REMARK 470 LYS F 688 CG CD CE NZ REMARK 470 LYS G 688 CG CD CE NZ REMARK 470 HIS G 691 ND1 CD2 CE1 NE2 REMARK 470 GLU G 696 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE B 461 -98.28 -110.19 REMARK 500 SER B 468 37.21 -71.63 REMARK 500 ARG B 548 67.30 29.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 855 DISTANCE = 6.44 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 36J A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 36J B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 604 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4MG8 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH ALPHA-ZEARALANOL. DBREF 4TUZ A 302 552 UNP P03372 ESR1_HUMAN 302 552 DBREF 4TUZ B 302 552 UNP P03372 ESR1_HUMAN 302 552 DBREF 4TUZ F 686 698 PDB 4TUZ 4TUZ 686 698 DBREF 4TUZ G 686 698 PDB 4TUZ 4TUZ 686 698 SEQADV 4TUZ GLY A 298 UNP P03372 EXPRESSION TAG SEQADV 4TUZ SER A 299 UNP P03372 EXPRESSION TAG SEQADV 4TUZ HIS A 300 UNP P03372 EXPRESSION TAG SEQADV 4TUZ MET A 301 UNP P03372 EXPRESSION TAG SEQADV 4TUZ SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 4TUZ GLY B 298 UNP P03372 EXPRESSION TAG SEQADV 4TUZ SER B 299 UNP P03372 EXPRESSION TAG SEQADV 4TUZ HIS B 300 UNP P03372 EXPRESSION TAG SEQADV 4TUZ MET B 301 UNP P03372 EXPRESSION TAG SEQADV 4TUZ SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 255 GLY SER HIS MET LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 A 255 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 A 255 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 A 255 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 A 255 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 A 255 ARG VAL PRO GLY PHE VAL ASP LEU THR LEU HIS ASP GLN SEQRES 7 A 255 VAL HIS LEU LEU GLU CSO ALA TRP LEU GLU ILE LEU MET SEQRES 8 A 255 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 A 255 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 A 255 GLY LYS CYS VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 A 255 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 A 255 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 A 255 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 A 255 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 A 255 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 A 255 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 A 255 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 A 255 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CSO LYS SEQRES 19 A 255 ASN VAL VAL PRO LEU SER ASP LEU LEU LEU GLU MET LEU SEQRES 20 A 255 ASP ALA HIS ARG LEU HIS ALA PRO SEQRES 1 B 255 GLY SER HIS MET LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 B 255 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 B 255 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 B 255 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 B 255 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 B 255 ARG VAL PRO GLY PHE VAL ASP LEU THR LEU HIS ASP GLN SEQRES 7 B 255 VAL HIS LEU LEU GLU CSO ALA TRP LEU GLU ILE LEU MET SEQRES 8 B 255 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 B 255 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 B 255 GLY LYS CSO VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 B 255 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 B 255 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 B 255 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 B 255 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 B 255 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 B 255 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 B 255 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 B 255 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CSO LYS SEQRES 19 B 255 ASN VAL VAL PRO LEU SER ASP LEU LEU LEU GLU MET LEU SEQRES 20 B 255 ASP ALA HIS ARG LEU HIS ALA PRO SEQRES 1 F 13 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER SEQRES 1 G 13 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER MODRES 4TUZ CSO A 381 CYS MODIFIED RESIDUE MODRES 4TUZ CSO A 530 CYS MODIFIED RESIDUE MODRES 4TUZ CSO B 381 CYS MODIFIED RESIDUE MODRES 4TUZ CSO B 417 CYS MODIFIED RESIDUE MODRES 4TUZ CSO B 530 CYS MODIFIED RESIDUE HET CSO A 381 11 HET CSO A 530 7 HET CSO B 381 11 HET CSO B 417 7 HET CSO B 530 7 HET 36J A 601 23 HET GOL A 602 6 HET EDO A 603 4 HET GOL A 604 6 HET 36J B 601 23 HET EDO B 602 4 HET GOL B 603 6 HET GOL B 604 6 HETNAM CSO S-HYDROXYCYSTEINE HETNAM 36J (3S,7R,11E)-7,14,16-TRIHYDROXY-3-METHYL-3,4,5,6,7,8,9, HETNAM 2 36J 10-OCTAHYDRO-1H-2-BENZOXACYCLOTETRADECIN-1-ONE HETNAM GOL GLYCEROL HETNAM EDO 1,2-ETHANEDIOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 CSO 5(C3 H7 N O3 S) FORMUL 5 36J 2(C18 H24 O5) FORMUL 6 GOL 4(C3 H8 O3) FORMUL 7 EDO 2(C2 H6 O2) FORMUL 13 HOH *265(H2 O) HELIX 1 AA1 SER A 305 LEU A 310 1 6 HELIX 2 AA2 THR A 311 GLU A 323 1 13 HELIX 3 AA3 SER A 338 LYS A 362 1 25 HELIX 4 AA4 GLY A 366 LEU A 370 5 5 HELIX 5 AA5 THR A 371 SER A 395 1 25 HELIX 6 AA6 ARG A 412 LYS A 416 1 5 HELIX 7 AA7 GLY A 420 ASN A 439 1 20 HELIX 8 AA8 GLN A 441 SER A 456 1 16 HELIX 9 AA9 GLY A 457 PHE A 461 5 5 HELIX 10 AB1 GLU A 471 ALA A 493 1 23 HELIX 11 AB2 THR A 496 LYS A 531 1 36 HELIX 12 AB3 SER A 537 ALA A 546 1 10 HELIX 13 AB4 LEU B 306 LEU B 310 5 5 HELIX 14 AB5 THR B 311 GLU B 323 1 13 HELIX 15 AB6 SER B 338 VAL B 364 1 27 HELIX 16 AB7 GLY B 366 LEU B 370 5 5 HELIX 17 AB8 THR B 371 SER B 395 1 25 HELIX 18 AB9 ASN B 413 VAL B 418 5 6 HELIX 19 AC1 MET B 421 ASN B 439 1 19 HELIX 20 AC2 GLN B 441 SER B 456 1 16 HELIX 21 AC3 SER B 468 ALA B 493 1 26 HELIX 22 AC4 THR B 496 LYS B 531 1 36 HELIX 23 AC5 SER B 537 ALA B 546 1 10 HELIX 24 AC6 ILE F 689 LEU F 694 1 6 HELIX 25 AC7 ILE G 689 LEU G 694 1 6 SHEET 1 AA1 2 LYS A 401 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 LINK C GLU A 380 N CSO A 381 1555 1555 1.33 LINK C CSO A 381 N ALA A 382 1555 1555 1.33 LINK C LYS A 529 N CSO A 530 1555 1555 1.33 LINK C CSO A 530 N LYS A 531 1555 1555 1.33 LINK C GLU B 380 N CSO B 381 1555 1555 1.33 LINK C CSO B 381 N ALA B 382 1555 1555 1.33 LINK C LYS B 416 N CSO B 417 1555 1555 1.33 LINK C CSO B 417 N VAL B 418 1555 1555 1.33 LINK C LYS B 529 N CSO B 530 1555 1555 1.33 LINK C CSO B 530 N LYS B 531 1555 1555 1.33 CISPEP 1 THR B 465 LEU B 466 0 4.50 CISPEP 2 LEU B 466 LYS B 467 0 -5.59 SITE 1 AC1 13 LEU A 346 LEU A 349 ALA A 350 GLU A 353 SITE 2 AC1 13 LEU A 387 MET A 388 LEU A 391 PHE A 404 SITE 3 AC1 13 MET A 421 LEU A 428 GLY A 521 HIS A 524 SITE 4 AC1 13 LEU A 525 SITE 1 AC2 5 TYR A 331 ASN A 407 LEU A 408 LEU A 409 SITE 2 AC2 5 GLN A 414 SITE 1 AC3 2 GLU A 323 TRP A 393 SITE 1 AC4 7 GLU A 353 GLY A 390 ARG A 394 PHE A 445 SITE 2 AC4 7 LYS A 449 HOH A 731 HOH A 754 SITE 1 AC5 12 LEU B 346 LEU B 349 ALA B 350 GLU B 353 SITE 2 AC5 12 LEU B 387 MET B 388 LEU B 391 MET B 421 SITE 3 AC5 12 LEU B 428 GLY B 521 HIS B 524 LEU B 525 SITE 1 AC6 1 TRP B 393 SITE 1 AC7 3 GLN B 441 GLU B 444 ALA B 493 SITE 1 AC8 7 GLU B 323 ILE B 326 GLY B 390 ARG B 394 SITE 2 AC8 7 PHE B 445 LYS B 449 HOH B 730 CRYST1 55.960 83.430 58.770 90.00 108.59 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017870 0.000000 0.006011 0.00000 SCALE2 0.000000 0.011986 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017952 0.00000